Why Antidepressants Don't Work for Everyone — The Root Causes of Depression and How to Actually Heal
A holistic approach to depression that treats root causes, not just symptoms
If you've done everything the system recommended and still don't feel like yourself, this isn't a failure of willpower. It's a failure of the model. Here is the complete map.
There is a particular kind of suffering that comes from doing everything right and still not getting better.
You took the medication. You went to therapy. You read the books, kept the journal, maybe tried meditation. And still, somewhere beneath the daily function — the meetings attended, the meals prepared, the face that looks fine — there is a flatness that won't lift. A glass wall between you and your own life. A tiredness that sleep doesn't fix.
If you've been in that place, this article is for you. Not for the person still deciding whether something is wrong. For the person who already knows, who has already tried the obvious things, and who is ready — actually ready — to look at the full picture and do something about it.
What follows is not a criticism of psychiatry, and it is not a collection of wellness tips. It is a complete map of what depression actually is, where it comes from across multiple systems, and what a genuine path through it looks like. Not symptom management. Not a better chemical patch. But actual healing.
That map is more complex than a chemical imbalance. It is also, ultimately, more hopeful.
Do Antidepressants Work? What the Evidence Actually Shows
The short answer: antidepressants work for some people, partially for many, and not at all for a significant minority — and the model they're built on is increasingly contested.
When someone is diagnosed with depression today, the standard response is an SSRI or SNRI, targeting serotonin or norepinephrine. This approach is built on the monoamine hypothesis: the idea that depression is primarily a deficiency of certain neurotransmitters in the brain.
The hypothesis is not baseless. A subset of people respond meaningfully to antidepressants, and in acute or severe depression, medication can be a legitimate and necessary stabilising tool. None of what follows is an argument against using it when it's needed.
But the evidence for the monoamine hypothesis as a complete explanation of depression has been eroding for years. Between 30% and 40% of people prescribed antidepressants don't experience adequate relief from the first medication tried. A 2022 umbrella review of 17 meta-analyses in Molecular Psychiatry by Moncrieff and colleagues found no consistent evidence that people with depression have lower serotonin levels than those without — challenging the foundational premise of the chemical imbalance narrative that has dominated psychiatry for four decades.
The deeper problem is not whether serotonin is involved — it almost certainly is, as part of a much larger picture. The deeper problem is that the monoamine hypothesis doesn't explain the why. Neurochemistry doesn't go out of balance randomly. Something happens — in the body, in the nervous system, in early relationships, in the conditions of a person's life — that dysregulates the brain's chemistry over time. Treating the downstream result while leaving the upstream causes untouched is, at best, a temporary fix. The leaking tap is still running.
The upstream causes are what this article is about.
What Actually Causes Depression? A Systems Map
Depression is not one thing. It is the output of multiple interacting systems — biological, neurological, psychological, relational, and existential — all of which influence each other and all of which can degrade or restore the others.
Understanding this is the difference between managing symptoms and actually recovering.
Systems thinking asks a different question than conventional medicine. Rather than "what is wrong with this person's serotonin?", it asks: what conditions produced this state, across all the systems that contribute to it? And: which of those systems is currently dysregulated, and in what direction?
The map that follows covers six systems. They are not independent. A disruption in one will, over time, disrupt the rest. And recovery — genuine, lasting recovery — requires attending to all of them, not just the most visible.
Is Depression a Physical Illness? The Mitochondria-Depression Link
Yes. Depression has a measurable biological substrate — and one of the most important, least-discussed dimensions of it involves the energy-producing machinery inside your cells.
Mitochondria are the organelles inside every cell responsible for converting nutrients into ATP — the chemical currency the body uses to power every biological process. The brain, which accounts for roughly 2% of body weight but consumes approximately 20% of the body's total energy, is acutely dependent on this supply.
In people with depression, that supply is compromised. Multiple peer-reviewed studies have documented reduced ATP production in brain tissue, impaired mitochondrial respiratory function, elevated oxidative stress, and damage to mitochondrial DNA in depressed patients. A 2023 meta-analysis in BMC Psychiatry found consistent alterations in mitochondrial DNA content across peripheral blood and cerebrospinal fluid in people with depression. A 2024 review in CNS Neuroscience & Therapeutics (Jiang et al.) identified impaired brain energy metabolism as a central etiological factor in major depressive disorder — not a side effect of it.
This matters for the lived experience of depression in ways that are immediately recognisable: the bone-deep fatigue that sleep doesn't fix, the cognitive fog, the body that doesn't want to move, the difficulty initiating tasks that once felt effortless. These are not only metaphors for emotional pain. They are, in part, direct biological consequences of an energy-depleted brain.
What causes mitochondrial dysfunction in depression? The causes are interconnected with every other system on this map:
Chronic psychological stress elevates cortisol over sustained periods and directly impairs mitochondrial membrane function. Emotional conflict, work overwhelm, relational pain — all of it registers at the cellular level.
Systemic inflammation: inflammatory cytokines — particularly TNF-α, IL-6, and IL-1β — are consistently elevated in people with depression and impair mitochondrial respiration directly.
Nutritional deficiencies: mitochondria depend on adequate magnesium, zinc, B vitamins, omega-3 fatty acids, CoQ10, and antioxidants. Deficiency in any of these degrades their function.
Disrupted sleep: the brain's glymphatic waste-clearance system operates primarily during sleep. Chronic disruption compounds every other biological burden.
Sedentary behaviour: movement triggers BDNF release and mitochondrial biogenesis — deprive the body of movement and both atrophy.
What can you do about it? The biological optimisation toolkit for depression
What the longevity and biohacking communities have understood for some time — and what clinical research is now validating — is that biological systems can be actively supported, not just treated when they fail:
Targeted supplementation with documented evidence in depression: omega-3s (EPA/DHA at therapeutic doses of 1–2g EPA daily), magnesium glycinate or threonate, zinc, methylated B-complex including methylfolate, vitamin D3 with K2, CoQ10 as mitochondrial cofactor, N-acetylcysteine (NAC) for oxidative stress, and creatine monohydrate. Creatine deserves specific mention: it plays a direct role in cellular ATP regeneration and has an accumulating evidence base in depression, with multiple trials showing that 3–5g daily reduces depressive symptoms, particularly in women and treatment-resistant cases — likely because it addresses the energy deficit at the cellular level the mitochondrial research identifies.
Nutrition — two evidence-based pathways: The conventional approach prioritises diverse fibre, polyphenol-rich foods, fermented foods, and reduced ultra-processed food. This works well for many people and directly supports the gut microbiome (see the next section). But it is not the only validated path. A 2025 meta-analysis across 50 studies and 41,718 participants in JAMA Psychiatry found that ketogenic nutrition produces meaningful reductions in depressive symptoms, with stronger effects when ketosis is biochemically verified. Stanford's metabolic psychiatry research (Sethi et al., 2024) found ketogenic intervention improved both metabolic and psychiatric outcomes in serious mental illness. The mechanism is distinct from fibre-based approaches but complementary to the mitochondrial picture: ketone bodies provide an alternative fuel that can bypass some of the damaged respiratory chain steps documented in depressed brains, while reducing glycaemic variability and the cortisol spikes that accompany blood sugar crashes. This is not universally appropriate and requires supervision, but it belongs in the evidence-based toolkit.
Sleep architecture: consistent sleep and wake times, darkness, and temperature regulation are upstream inputs to every other system. Not lifestyle variables — prerequisites.
Movement, calibrated to your current capacity: for people who are not severely depleted, exercise is comparable to antidepressants in mild-to-moderate depression and meaningfully additive in more severe presentations (multiple meta-analyses confirm this). The mechanisms include BDNF upregulation, mitochondrial biogenesis, and HPA axis regulation. However, prescribing vigorous exercise to someone already in burnout-level depletion is the wrong medicine at the wrong time. What works at every level of depletion — and is backed by its own evidence base — is walking in nature. A 2025 meta-analysis found that walking in natural environments significantly reduced depression and anxiety, while walking in urban environments showed no equivalent benefit. A 2024 systematic review of 17 studies and over 1,200 participants confirmed that nature-based walking interventions consistently improve mood and mental wellbeing. They lower cortisol, engage the parasympathetic nervous system, and reduce rumination without demanding reserves many depressed people don't have.
Addressing the biological foundation is the first phase of genuine recovery — not because it resolves depression on its own, but because none of the deeper work is reliably possible when the organism is running on empty.
Does the Gut Microbiome Affect Depression? What the Research Shows
Yes — and the mechanism is direct, anatomical, and increasingly well-documented. Approximately 90% of the body's serotonin is produced in the gut, not the brain.
The enteric nervous system — sometimes called the "second brain" — contains more neurons than the spinal cord and communicates bidirectionally with the brain via the vagus nerve, the body's longest cranial nerve. The gut microbiome, the ecosystem of trillions of microorganisms living in the intestinal tract, directly influences mood regulation, inflammation, and neurotransmitter production.
A 2024 paper in Frontiers in Immunology describes the microbiota-gut-brain axis as a complex bidirectional communication network involving the intestinal barrier, the immune system, the vagus nerve, and the central nervous system. When the microbiome is dysregulated — a state called dysbiosis — the consequences include impaired serotonin precursor availability, increased systemic inflammation, and disrupted neurotransmitter balance reaching the brain.
A landmark 2023 study in Molecular Psychiatry demonstrated the mechanism directly in vivo: transplanting gut microbiota from stressed, depressed mice into healthy ones induced sustained depression-like behaviour, reduced hippocampal neurogenesis, and neuroinflammatory responses — specifically via the gut-vagus nerve pathway. These effects were abolished when the vagus nerve was severed, confirming that gut-to-brain transmission of depressive signals is literal and anatomical, not merely correlational.
What disrupts the microbiome? Chronic stress, antibiotics, ultra-processed food, high sugar intake, alcohol, and low dietary fibre. What restores it? Diverse plant-based fibre, fermented foods (kefir, yogurt, kimchi, sauerkraut), reduced processed food, and where indicated, targeted probiotic support. The research on specific strains and depression is still developing, but the directional evidence is consistent.
If 90% of serotonin is produced in your gut, and the gut directly regulates the brain's mood-regulating capacity, any approach to depression that ignores gut health is treating the wrong address.
Why Can't You Think Your Way Out of Depression? The Nervous System and Survival States
Because the nervous system's primary function is not to make you happy — it is to keep you alive. And a nervous system locked in a survival state cannot be reasoned out of it.
The autonomic nervous system operates in service of survival. When it perceives threat — physical, emotional, relational, or existential — the sympathetic branch activates fight-or-flight. In situations of overwhelming, inescapable threat, the older dorsal vagal pathway triggers shutdown: immobility, numbness, disconnection, profound fatigue. If you've experienced depression that feels less like sadness and more like being switched off at the source, this is the mechanism.
The problem arises when survival states become chronic. When threat is not a temporary event but an ongoing condition — unresolved trauma, a life situation that feels inescapable, years of stress that never fully unwind — the nervous system doesn't return to regulation. It adapts to dysregulation. The shutdown or hypervigilant state stops being a response and becomes, simply, how things are.
What does the neuroscience of learned helplessness say about depression?
Seligman and Maier's model of learned helplessness, first published in 1967 and updated with neuroscientific precision in a landmark 2016 paper in Current Biology, demonstrated something that overturns the conventional story: passivity in the face of overwhelming circumstances is not a learned behaviour. It is the brain's default response to prolonged, uncontrollable aversive events, mediated by serotonergic activity in the dorsal raphe nucleus. What has to be actively learned is controllability — the lived experience that your actions produce outcomes.
Depression and learned helplessness share the same neural machinery. And the neurobiological path out of learned helplessness, as Seligman's updated research documents, is not insight or cognitive reframing. It is the repeated embodied experience of agency — small, concrete moments in which the organism discovers that what it does matters.
This has direct implications for treatment. Any approach to depression that leaves the person in conditions that continue to overwhelm their nervous system — regardless of the therapy or medication it adds on top — will produce, at best, partial and temporary results.
Why talk therapy alone often isn't enough for trauma-rooted depression
Gabor Maté's work, documented in The Myth of Normal (2022) and When the Body Says No (2003), consistently identifies unresolved trauma at the root of chronic patterns of suffering — not necessarily dramatic trauma, but often the quieter kind: years of emotional unavailability in a primary caregiver, feelings dismissed, vulnerability punished, needs treated as inconvenient.
Trauma is not an event. It is what happens inside the organism in response to an event that overwhelms its capacity to cope. And as van der Kolk's research in The Body Keeps the Score documents, trauma is stored not in memory alone but in the body itself — in the patterns of the nervous system, chronic tension, dysregulated breathing, a baseline activation level that feels, after long enough, simply like who you are.
This is why cognitive understanding of what happened doesn't fully heal what is held somatically. The nervous system needs different inputs to shift: body-based practices, somatic work, breathwork, movement — and in certain contexts, the kind of deep neurobiological reset that plant medicines can facilitate.
How Do Childhood Trauma and Attachment Patterns Drive Adult Depression?
The nervous system doesn't seek happiness. It seeks the familiar. And for many people with depression, the familiar was never safe — but the nervous system learned to call it home.
Research on trauma bonding and attachment patterns consistently shows that people raised in homes with abuse, neglect, or emotional inconsistency are significantly more likely to form adult relationships that replicate those dynamics. Not because they want to recreate the pain. Not because they are broken or choosing poorly. But because the nervous system reads familiarity as safety — and it was calibrated in an environment where those two things were the same.
Decades later, that calibration is still running. It shapes who feels comfortable, which relationships are pursued, which situations feel like home even when they harm. The abusive-childhood-to-abusive-relationship pattern is not a character flaw. It is the nervous system navigating toward what it knows.
Understanding this is not an invitation to despair. It is the first moment of genuine leverage — because patterns that were learned can, with the right work, be unlearned. The nervous system is plastic. New calibration is possible. But it requires more than insight.
The cycle is not broken by knowing it exists. It breaks through the lived experience of something different: different relational attunement, different somatic inputs, a different embodied sense of what safety actually feels like. This is why somatic and relational work are not supplements to healing — in many cases they are the primary mechanism of it.
The relational environment: the condition everything else depends on
There is a dimension that clinical discussions rarely address with sufficient directness: recovery is profoundly difficult when you remain in close proximity to the person or patterns that either created the original wound or actively reinforce it.
This is not about blame. A person who is dismissive, controlling, or emotionally dysregulating is almost certainly themselves operating from unresolved nervous system patterns. The question is not whether they are bad. The question is what happens to your nervous system in their consistent presence. A nervous system learning to regulate cannot do so while being repeatedly dysregulated by the same source.
Boundaries are not built by confronting their most charged version first. They are built gradually, practiced initially in relationships where the felt sense of safety is higher — and then extending outward as that capacity grows. Trying to renegotiate a fundamental relationship with a parent or long-term partner before that capacity has been developed elsewhere usually produces flooding, not empowerment.
Research on adverse childhood experiences (ACEs) consistently finds that early environments in which a child's needs were consistently dismissed or overridden leave an adult carrying a largely unconscious belief: I do not have the right to take up space. My needs are not important. I cannot trust my own perception. This operates below conscious thought. It shapes posture, what opportunities are pursued, which relationships are tolerated. It generates, over time, a life that does not fully belong to the person living it.
Depression, viewed through this lens, is not a malfunction. It is a signal. The body and psyche asking, insistently: this is not your life. Something needs to change.
The path forward is not to suppress the signal. It is to follow it.
Does Psychedelic Therapy Work for Treatment-Resistant Depression?
Yes — and the clinical evidence is now substantial. More importantly, the mechanism explains why psychedelic therapy can succeed where conventional antidepressants have repeatedly failed.
In the last decade, peer-reviewed clinical trials at Imperial College London, Johns Hopkins, and in international multi-centre RCTs have demonstrated rapid, meaningful, and in some cases sustained reductions in depression following psilocybin-assisted therapy — including in treatment-resistant cases where multiple rounds of antidepressants had produced no adequate response.
A 2022 international multi-centre RCT published in NEJM Evidence found significant efficacy for a 25mg psilocybin dose in treatment-resistant depression. A 2023 Swiss double-blind RCT showed response rates of 58% in the psilocybin group versus 16% placebo, with remission rates of 54% versus 12% at the primary endpoint. These are not modest effects.
Why does psilocybin work when antidepressants haven't? The TrkB-BDNF mechanism
In 2023, Moliner and colleagues published research in Nature Neuroscience showing that psilocybin binds directly to TrkB — the primary receptor for BDNF (brain-derived neurotrophic factor), the brain's key neuroplasticity-promoting molecule — with an affinity approximately 1,000 times greater than that of conventional antidepressants. BDNF is the molecule most responsible for the brain's capacity to form new connections, update old ones, and break out of the rigid, self-reinforcing circuits that characterise chronic depression.
In plain terms: psilocybin doesn't just modulate serotonin. It directly activates the biological machinery the brain uses to change itself. Research has further shown that a single dose can rapidly and persistently increase dendritic spine density in the medial prefrontal cortex and hippocampus — structural changes lasting weeks after the acute experience.
What is the neuroplasticity window after a psychedelic experience?
The hours and days following a psychedelic experience represent a period of heightened biological plasticity — a window in which the brain is actively more receptive to new learning, new relational experiences, and new patterns of thought and behaviour. Research on BDNF and synaptic remodelling suggests this window persists for days to weeks after the experience.
What happens in that window largely determines whether the neuroplasticity consolidates into lasting change, or whether the brain returns to its previous patterns. This is why psychedelic-assisted therapy — with structured preparation, facilitated ceremony, and ongoing integration support — produces fundamentally different outcomes than unguided recreational use. The medicine opens the window. What you do in it shapes what comes through.
Why nervous system stabilisation must come before psychedelic work
A nervous system that is chronically dysregulated — running on cortisol, nutritionally depleted, biologically overwhelmed — is not well-positioned to integrate the deep psychological material that psychedelics surface. The body is already at capacity. Adding the amplifying lens of a plant medicine experience to a system with no capacity for regulated self-observation often produces fear rather than insight, flooding rather than release.
This is the clinical and practical rationale behind the BioPsyche Renewal Protocol (BPR) sequence: Stabilize → Illuminate → Embody. Stabilise the biological and nervous system foundations first. Then use plant medicine to illuminate what is underneath, in a system prepared to receive it. Then embody the insights through integration, somatic work, and the gradual restructuring of daily life.
The Illuminate phase — when the timing is right — is what our 5-Day Flexible Reset Retreat is built around: a multi-medicine supported experience in a small group (maximum 8 guests) with preparation, ceremonial facilitation, and integration woven through the entire arc.
For those wanting to explore the full BPR framework for depression recovery specifically, the BioPsyche Renewal depression recovery programme provides a structured path through all three phases.
Does Finding Meaning in Life Help with Depression? Viktor Frankl and the Evidence
Yes — and the mechanism is both psychological and neurobiological. A life experienced as purposeless is not merely philosophically unsatisfying. It is depressogenic.
Viktor Frankl survived four Nazi concentration camps — Auschwitz among them. He lost his wife, his parents, and his brother. In conditions designed to strip human beings of every remnant of selfhood, he observed that the people most likely to survive were those who had something to live for. Not comfort. Not certainty. But a frame within which suffering was bearable — a reason that gave meaning to the endurance.
His conclusion, articulated in Man's Search for Meaning, became the foundation of logotherapy: the primary human motivation is not pleasure (Freud) or power (Adler) but the search for meaning. And this search — frustrated, absent, or abandoned — lies at the root of a significant dimension of human suffering.
A 2016 systematic review of logotherapy's evidence base (Thir & Batthyány) found consistent correlations between lower sense of meaning and clinical depression, and consistent relationships between presence of meaning and both resilience and life satisfaction. Frankl's concept of the "existential vacuum" — boredom, apathy, emptiness, purposelessness — maps directly onto what many people with depression describe when asked not about their symptoms but about their lives: a sense that they are executing someone else's script, that the goals they are pursuing no longer feel like their own, that even achieving them brings not satisfaction but a deeper hollow.
How do you find meaning when you're depressed?
Frankl was careful to distinguish discovering meaning from creating it. Meaning, in his framework, is not manufactured through positive thinking. It is found — in work that genuinely matters, in love that is authentic, in suffering that can be given a frame within which it becomes bearable. And it is unique to each person. No one else can tell you what your meaning is. They can only help you get quiet enough to hear it.
That quieting — the silencing of the noise of other people's expectations, the numbing of performance and achievement and status — is itself part of what deep work with plant medicines can facilitate. Many people who have worked with ayahuasca or psilocybin in a supported setting describe an encounter with what actually matters to them that cuts through, often for the first time in years, the accumulated layers of what they should want.
This is not mysticism. It is what becomes accessible when the default mode network — the brain's self-referential thought network, consistently overactive in depression — briefly releases its grip.
What Does a Complete, Evidence-Based Approach to Healing Depression Look Like?
A complete approach to depression addresses all six systems — not simultaneously, not all at equal depth, but without leaving any of them entirely unattended. The sequence matters as much as the content.
Bringing the map together:
The biological layer — Stabilize: address nutritional foundations, sleep architecture, inflammatory load, gut microbiome, and movement. This is the prerequisite — not because it resolves depression, but because the organism running on empty cannot do the rest. This includes targeted supplementation, food as medicine, and the recovery of basic physiological regulation.
The nervous system layer — Stabilize continuing: recognise dysregulation as an intelligent survival response, not a character flaw. Introduce somatic practices — breathwork, body-based regulation, nature immersion. Create enough physiological safety for the deeper work to become possible.
The trauma and pattern layer — Illuminate: explore, with appropriate support, the early experiences that shaped the nervous system's current calibration. Not to assign blame, but to locate the roots of patterns that are no longer serving. This is where plant medicine, done responsibly with preparation and integration support, can provide access that talk therapy alone often cannot reach. For the right person at the right moment, the 5-Day Flexible Reset Retreat provides a structured, small-group context for this work.
The relational layer — Illuminate and Embody: understand the attachment patterns that have made genuine connection difficult. Build the capacity for real intimacy — not its performance — beginning in conditions of relative safety and extending outward. Address the relational context actively if it is a source of ongoing dysregulation.
The meaning layer — Embody: engage honestly with the question of purpose. Not "what should I want" but "what do I actually find meaningful?" This is an ongoing practice of listening beneath the noise, and it is the dimension that sustains recovery once the other systems are addressed.
Throughout — agency: the gradual, embodied rebuilding of the knowledge that your actions produce outcomes, that your choices matter, that the direction of your life is not fixed. This is not a mindset shift. It is a neurobiological process, confirmed through small repeated experiences of efficacy across all the other layers.
For a structured path through all three phases — Stabilize, Illuminate, Embody — the BioPsyche Renewal depression recovery programme was developed specifically to address this full picture.
None of this is quick. None of it is linear. And none of it is done alone.
But here is what the research, and the lived experience of the hundreds of people we have worked with, consistently confirms: this kind of multi-system engagement produces something that antidepressants alone, or talk therapy alone, or any single intervention rarely achieves.
It produces people who don't just manage their depression. It produces people who no longer generate it — because the conditions of their lives, internal and external, have genuinely changed.
That is the map. Where you start on it depends on where you are now. But every part of it is navigable.
At Vine of the Soul Retreats, the BioPsyche Renewal Protocol was developed specifically to address this full picture — stabilising the nervous system and biological foundations, illuminating the roots through supported plant medicine work, and embodying lasting change through integration. If you'd like to explore whether our work might be the right fit for you, you're welcome to get in touch.
Research References
Moncrieff J et al. (2022). The serotonin theory of depression: umbrella review. Molecular Psychiatry.
Song Y et al. (2023). Mitochondrial dysfunction: A fatal blow in depression. Biomedicine & Pharmacotherapy, 167.
Jiang et al. (2024). Mitochondria in depression. CNS Neuroscience & Therapeutics, 30(2).
Larrea A et al. (2024). Mitochondrial Metabolism in Major Depressive Disorder. Journal of Clinical Medicine, 13(6).
BMC Psychiatry (2023). Mitochondrial DNA levels and depression: meta-analysis.
Chevalier et al. (2023). Gut microbiota changes require vagus nerve integrity. Molecular Psychiatry.
Frontiers in Immunology (2025). Microbiota-gut-brain axis in depression.
PMC (2024). Bidirectional relationship between gut microbiome and mental health.
Maier SF & Seligman MEP (2016). Learned helplessness at fifty. Current Biology.
Baratta MV & Seligman MEP (2023). From helplessness to controllability. Frontiers in Psychiatry.
Porges SW (2024). Polyvagal Theory: Current Status. PMC.
Goodwin GM et al. (2022). Phase 2 RCT psilocybin TRD. NEJM Evidence.
Moliner R et al. (2023). Psilocybin binds TrkB at high affinity. Nature Neuroscience.
OPEN Foundation (2025). Psilocybin and Neuroplasticity review.
Thir M & Batthyány A (2016). Evidence base for logotherapy: systematic review.
Frankl VE. Man's Search for Meaning (1946/2006). Beacon Press.
Van der Kolk B. The Body Keeps the Score (2014). Viking.
Maté G. The Myth of Normal (2022). Avery.
Sethi S et al. (2024). Ketogenic diet in serious mental illness. Psychiatry Research, 335.
Phillips MCL et al. (2025). Ketogenic diets and depression: meta-analysis. JAMA Psychiatry.
Kious BM et al. Creatine supplementation for depression. University of Utah RCTs.
Ma J et al. (2024). Nature-based walking interventions. Current Psychology, 43.
Last updated